The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression

NCT07699445 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Bipolar Depression Depressed Phase
Obesity & Overweight

Interventions

DRUG: Lumateperone 42 mg

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]